Insmed Incorporated
INSM
$189.70
$4.022.17%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 32.52% | 15.72% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 32.52% | 15.72% | |||
| Cost of Revenue | 4.59% | 31.94% | |||
| Gross Profit | 42.40% | 10.90% | |||
| SG&A Expenses | 20.43% | 4.89% | |||
| Depreciation & Amortization | 21.77% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 11.74% | 11.97% | |||
| Operating Income | -2.94% | -10.46% | |||
| Income Before Tax | -15.06% | -25.33% | |||
| Income Tax Expenses | 6.19% | 36.29% | |||
| Earnings from Continuing Operations | -15.03% | -25.37% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -15.03% | -25.37% | |||
| EBIT | -2.94% | -10.46% | |||
| EBITDA | -2.88% | -10.31% | |||
| EPS Basic | -2.83% | -19.78% | |||
| Normalized Basic EPS | 9.72% | -5.23% | |||
| EPS Diluted | -2.94% | -19.72% | |||
| Normalized Diluted EPS | 9.72% | -5.23% | |||
| Average Basic Shares Outstanding | 11.86% | 4.67% | |||
| Average Diluted Shares Outstanding | 11.86% | 4.67% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||